Value Bridge — EISENHOWER MEDICAL CENTER
Current $-122M → Target $-99M (+$22.9M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-122.0M
Current EBITDA
$-99.1M
Target EBITDA
+$22.9M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$5.2M
Payer Mix Optimization
$12.4M
Cost to Collect Reduction
$4.1M
Clean Claim Improvement
$3.1M
Volume & Rate Growth
$20.7M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-122M to $-99M. The highest-impact lever is Volume & Rate Growth at $8.3M probability-weighted.
IC talking point: "We see $23M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $252M in equity value creation."